CCL2 and colitis: These data are also consistent with that of a recent study showing that CBDV treatment attenuated MCP-1 mRNA levels in colonic tissue post-colitis.34 Of interest, this study also showed that CBDV was able to reduce intestinal permeability, an effect that may be replicated at the BBB, but this has yet to be investigated.